EGFR and breast carcinoma: Breast cancer cells expressing the chondroitin sulfate proteoglycan member versican G3-domain exhibit enhanced migration and invasion to primary bone stromal cells or osteoblasts in part via the epidermal growth factor receptor (EGFR)/AKT axis.